Interactions of Pesticides with Cytochrome P-450

@inproceedings{Hodgson1974InteractionsOP,
  title={Interactions of Pesticides with Cytochrome P-450},
  author={E. Hodgson and A. Kulkarni},
  year={1974}
}
Review of and Recommendations for Monitoring Contaminants and their Effects in the San Francisco Bay−Delta
Author(s): Connon, Richard E.; Hasenbein, Simone; Brander, Susanne M.; Poynton, Helen C.; Holland, Erika B.; Schlenk, Daniel; Orlando, James L.; Hladik, Michelle L.; Collier, Tracy K.; Scholz,Expand
Introduction to Biotransformation (Metabolism)
Publisher Summary Xenobiotics include pesticides, occupational chemicals, clinical drugs, drugs of abuse, deployment-related chemicals, etc., and is a particularly useful term when discussingExpand
Metabolic Interactions of Pesticides
Publisher Summary This chapter illustrates the interactions of pesticides, which act as either enzyme inducers or inhibitors, affecting the metabolism of other xenobiotics, such as drugs, as well asExpand
Metabolism of Pesticides
TLDR
This chapter focuses on biotransformation as it applies to pesticides, with the aim of identifying human populations at increased risk and enabling comparative studies to be carried out at the level of specific isoforms of the XMEs involved. Expand
Bark beetle pheromones: evidence for physiological synthesis mechanisms and their ecological implications.
TLDR
The conclusion of this work is that the terpenoid-type bark beetle pheromones are probably microsomal cytochrome-P-450-produced metabolites of host terpenes, which contrasts with the ter penoids, which are the result of xenobiotic detoxification mechanisms. Expand
CHAPTER 23 – Metabolism of Pesticides
This chapter focuses on the metabolism or biotransformation of xenobiotics, especially pesticides. The metabolism of xenobiotics generally occurs in two phases. Phase I involves predominantlyExpand
Epidemiology, Outcomes Research, and Drug Interactions
  • J. Schein
  • Medicine
  • Drug metabolism and drug interactions
  • 1998
TLDR
This area is opportune for the application of epidemiological and outcomes-based studies on the true risk of a drug interaction, or the probability of such an interaction occurring in a given population, because a dearth of information is available. Expand
...
1
2
...